BA in Philosophy - Political and Legal Studies Concentration
Skills
Providing Excellent Customer Service • Superb Verbal/Written Communication Skills • Microsoft Office • Basic C++ knowledge • Basic Linux Knowledge • Payroll Processing Software
Isbn (Books And Publications)
The Forging of Bureaucratic Autonomy: Reputations, Networks, and Policy Innovation in Executive Agencies, 1862-1928
Dec 2009 to 2000 Dining Services SupervisorInkStop Chesapeake, VA Nov 2008 to Oct 2009 Assistant Store MangerGameStop Virginia Beach, VA Oct 2006 to Nov 2008 Key Holder/Sales Lead
Education:
Old Dominion University Norfolk, VA 2003 to 2009 BA in Philosophy - Political and Legal Studies Concentration
Skills:
Providing Excellent Customer Service, Superb Verbal/Written Communication Skills, Microsoft Office, Basic C++ knowledge, Basic Linux Knowledge, Payroll Processing Software
Writing recently in NEJM, Harvard Universitys Daniel Carpenter suggested that Gottliebs libertarian ideas about drug regulation would politicize the drug approval process, give deep-pocketed pharmaceutical companies a dangerous edge in the approvals process, and erode the safety and effectiveness
Date: Apr 06, 2017
Category: Health
Source: Google
Obama's Pick to Lead FDA Nears Senate Confirmation
Daniel Carpenter, a social scientist at Harvard University in Cambridge, Massachusetts, says that Califf's nomination will likely not be the last that sparks debate over potential industry influence in government.
Date: Feb 23, 2016
Category: Health
Source: Google
Ezra Klein: 23andme challenges a creaky regulatory state
The legal question is pretty simple, said Daniel Carpenter, author of Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA. The definition of a device under the Federal Food, Drug and Cosmetics Act, Carpenter said, is anything intended for the use or diagnosis of
Date: Dec 06, 2013
Category: Health
Source: Google
Viewpoints: Berwick's Advice; Romney's Wager; Fighting AIDS
The New York Times: Free The FDA The unilateral decision last week by Kathleen Sebelius, the secretary of health and human services, to block the Plan B One-Step contraceptive pill from being sold to adolescents without a prescription is shocking in more ways than one (Daniel Carpenter, 12/13)
In the aftermath of Sebeliuss decision, some are calling for the Food and Drug Administration to become more independent. Daniel Carpenter a professor of government at Harvard wrote in the New York Times yesterday that Sebeliuss decision sets a radical precedent:
The company has used a number of "philosophical and political arguments to oppose the FDA's proposed withdrawal of the indication," explained Daniel Carpenter, PhD, of the Department of Government at Harvard, who was the lead author of an online Perspective published Monday in the New England Journa